questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Métalloprotéines
Protéines de liaison au fer
Protéines à fer non hème
Lipoxygénases
Arachidonate lipoxygenases
Arachidonate 12-lipoxygenase
Arachidonate 12-lipoxygenase : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Lipoxygenases
Acides gras
Tests de laboratoire
Leucotriènes
Biomarqueurs
Acides gras
Tests génétiques
Mutations
Lipoxygenases
Inflammation
Douleur
Symptômes
Imagerie médicale
Inflammation
Lésions
Symptômes
5
Inflammation
Douleur
Symptômes
Asthme
Arthrite
Maladies inflammatoires
Infections
Déficience immunitaire
Signes cliniques
Inflammation
Rougeurs
Gonflement
Âge
Comorbidités
Symptômes
Prévention
5
Prévention
Mode de vie
Alimentation équilibrée
Exercice
Santé
Inflammation
Stress
Inflammation
Activité enzymatique
Suppléments
Oméga-3
Prévention
Poids santé
Inflammation
Gestion du poids
Traitements
5
Inhibiteurs
Traitements anti-inflammatoires
Lipoxygenases
Anti-inflammatoires
Acide arachidonique
Traitements
Thérapies alternatives
Acides gras oméga-3
Gestion des symptômes
Diététique
Acides gras
Nutrition
Corticostéroïdes
Inflammation
Traitements
Complications
5
Maladies cardiovasculaires
Troubles respiratoires
Complications
Cancer
Lipoxygénases
Complications
Maladies auto-immunes
Dysrégulation
Complications
Troubles neurologiques
Activité enzymatique
Complications
Inflammation chronique
Dommages tissulaires
Maladies dégénératives
Facteurs de risque
5
Obésité
Tabagisme
Facteurs de risque
Hérédité
Antécédents familiaux
Facteurs de risque
Mode de vie sédentaire
Inflammation
Facteurs de risque
Stress chronique
Inflammation
Activité enzymatique
Infections
Équilibre immunitaire
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Arachidonate 12-lipoxygenase : Questions médicales les plus fréquentes",
"headline": "Arachidonate 12-lipoxygenase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Arachidonate 12-lipoxygenase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-07",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Arachidonate 12-lipoxygenase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Arachidonate lipoxygenases",
"url": "https://questionsmedicales.fr/mesh/D001091",
"about": {
"@type": "MedicalCondition",
"name": "Arachidonate lipoxygenases",
"code": {
"@type": "MedicalCode",
"code": "D001091",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.556.579.374.568.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Arachidonate 12-lipoxygenase",
"alternateName": "Arachidonate 12-Lipoxygenase",
"code": {
"@type": "MedicalCode",
"code": "D001092",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hartmut Kuhn",
"url": "https://questionsmedicales.fr/author/Hartmut%20Kuhn",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany."
}
},
{
"@type": "Person",
"name": "Raghavendra G Mirmira",
"url": "https://questionsmedicales.fr/author/Raghavendra%20G%20Mirmira",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, The University of Chicago, Chicago, IL 60637, USA."
}
},
{
"@type": "Person",
"name": "Theodore R Holman",
"url": "https://questionsmedicales.fr/author/Theodore%20R%20Holman",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, CA."
}
},
{
"@type": "Person",
"name": "Klaus van Leyen",
"url": "https://questionsmedicales.fr/author/Klaus%20van%20Leyen",
"affiliation": {
"@type": "Organization",
"name": "Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, United States."
}
},
{
"@type": "Person",
"name": "Sabine Stehling",
"url": "https://questionsmedicales.fr/author/Sabine%20Stehling",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The effect of smoking on latent hazard classes of metabolic syndrome using latent class causal analysis method in the Iranian population.",
"datePublished": "2023-10-20",
"url": "https://questionsmedicales.fr/article/37864179",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-023-16863-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Part I: A friendly introduction to latent class analysis.",
"datePublished": "2022-05-27",
"url": "https://questionsmedicales.fr/article/35636591",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jclinepi.2022.05.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "Subgroups of borderline personality disorder: A latent class analysis.",
"datePublished": "2023-02-22",
"url": "https://questionsmedicales.fr/article/36905903",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psychres.2023.115131"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multimorbidity patterns in South Africa: A latent class analysis.",
"datePublished": "2023-01-11",
"url": "https://questionsmedicales.fr/article/36711391",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2022.1082587"
}
},
{
"@type": "ScholarlyArticle",
"name": "A two-step estimator for multilevel latent class analysis with covariates.",
"datePublished": "2023-08-06",
"url": "https://questionsmedicales.fr/article/37544973",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11336-023-09929-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Métalloprotéines",
"item": "https://questionsmedicales.fr/mesh/D008667"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de liaison au fer",
"item": "https://questionsmedicales.fr/mesh/D033862"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines à fer non hème",
"item": "https://questionsmedicales.fr/mesh/D019159"
},
{
"@type": "ListItem",
"position": 7,
"name": "Lipoxygénases",
"item": "https://questionsmedicales.fr/mesh/D058945"
},
{
"@type": "ListItem",
"position": 8,
"name": "Arachidonate lipoxygenases",
"item": "https://questionsmedicales.fr/mesh/D001091"
},
{
"@type": "ListItem",
"position": 9,
"name": "Arachidonate 12-lipoxygenase",
"item": "https://questionsmedicales.fr/mesh/D001092"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Arachidonate 12-lipoxygenase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Arachidonate 12-lipoxygenase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Arachidonate 12-lipoxygenase",
"description": "Comment diagnostiquer une dysfonction de l'arachidonate 12-lipoxygenase ?\nQuels marqueurs biochimiques sont associés à cette enzyme ?\nY a-t-il des tests génétiques pour l'arachidonate 12-lipoxygenase ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nComment l'imagerie peut-elle aider dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Arachidonate 12-lipoxygenase",
"description": "Quels sont les symptômes d'une suractivité de l'enzyme ?\nL'arachidonate 12-lipoxygenase est-elle liée à des maladies spécifiques ?\nQuels signes cliniques peuvent indiquer une déficience ?\nComment l'inflammation se manifeste-t-elle cliniquement ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Arachidonate 12-lipoxygenase",
"description": "Comment prévenir les troubles liés à l'enzyme ?\nY a-t-il des exercices recommandés ?\nLe stress a-t-il un impact sur l'activité de l'enzyme ?\nDes suppléments peuvent-ils aider à la prévention ?\nLa gestion du poids est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Arachidonate 12-lipoxygenase",
"description": "Quels traitements ciblent l'arachidonate 12-lipoxygenase ?\nLes anti-inflammatoires non stéroïdiens sont-ils efficaces ?\nY a-t-il des thérapies alternatives recommandées ?\nComment la diététique influence-t-elle l'activité de l'enzyme ?\nLes corticostéroïdes sont-ils utilisés dans ce contexte ?",
"url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Arachidonate 12-lipoxygenase",
"description": "Quelles complications peuvent survenir avec une suractivité de l'enzyme ?\nL'arachidonate 12-lipoxygenase est-elle liée au cancer ?\nComment les maladies auto-immunes sont-elles liées à cette enzyme ?\nDes troubles neurologiques peuvent-ils être associés ?\nQuels effets à long terme peut avoir une inflammation chronique ?",
"url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Arachidonate 12-lipoxygenase",
"description": "Quels facteurs de risque sont associés à une dysfonction de l'enzyme ?\nL'hérédité joue-t-elle un rôle dans les troubles liés à l'enzyme ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress chronique influence-t-il l'activité de l'enzyme ?\nLes infections fréquentes sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction de l'arachidonate 12-lipoxygenase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses biochimiques peuvent évaluer l'activité de l'enzyme."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biochimiques sont associés à cette enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les produits de dégradation des acides gras, comme les leucotriènes, peuvent être mesurés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests génétiques pour l'arachidonate 12-lipoxygenase ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations affectant l'enzyme."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes inflammatoires, comme des douleurs articulaires, peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment l'imagerie peut-elle aider dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut détecter des inflammations ou des lésions associées à des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une suractivité de l'enzyme ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivité peut entraîner des inflammations chroniques et des douleurs."
}
},
{
"@type": "Question",
"name": "L'arachidonate 12-lipoxygenase est-elle liée à des maladies spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est impliquée dans des maladies comme l'asthme et l'arthrite."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques peuvent indiquer une déficience ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une susceptibilité accrue aux infections peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment l'inflammation se manifeste-t-elle cliniquement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des rougeurs, des gonflements et des douleurs localisées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de comorbidités."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés à l'enzyme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir les troubles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des exercices recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des exercices réguliers peuvent améliorer la santé globale et réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur l'activité de l'enzyme ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber l'inflammation et affecter l'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils aider à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments d'oméga-3 peuvent contribuer à une meilleure régulation de l'enzyme."
}
},
{
"@type": "Question",
"name": "La gestion du poids est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé peut réduire le risque d'inflammation chronique."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent l'arachidonate 12-lipoxygenase ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques de l'enzyme peuvent être utilisés pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Les anti-inflammatoires non stéroïdiens sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire l'inflammation en inhibant la voie de l'acide arachidonique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies alternatives recommandées ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies comme l'acupuncture ou les oméga-3 peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Comment la diététique influence-t-elle l'activité de l'enzyme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en acides gras oméga-3 peut moduler l'activité de l'enzyme."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés dans ce contexte ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent prescrits pour réduire l'inflammation associée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une suractivité de l'enzyme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des maladies cardiovasculaires et des troubles respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'arachidonate 12-lipoxygenase est-elle liée au cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surproduction de produits lipoxygénés peut être associée à certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les maladies auto-immunes sont-elles liées à cette enzyme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une dysrégulation de l'enzyme peut contribuer à l'aggravation des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Des troubles neurologiques peuvent-ils être associés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études suggèrent un lien entre l'activité de l'enzyme et certains troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme peut avoir une inflammation chronique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une inflammation chronique peut entraîner des dommages tissulaires et des maladies dégénératives."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à une dysfonction de l'enzyme ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'obésité, le tabagisme et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans les troubles liés à l'enzyme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies inflammatoires peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut contribuer à l'inflammation et à la dysfonction enzymatique."
}
},
{
"@type": "Question",
"name": "Le stress chronique influence-t-il l'activité de l'enzyme ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber l'inflammation et affecter l'activité de l'enzyme."
}
},
{
"@type": "Question",
"name": "Les infections fréquentes sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections répétées peuvent perturber l'équilibre immunitaire et affecter l'enzyme."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/04/2025
Contenu vérifié selon les dernières recommandations médicales
7 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
4 publications dans cette catégorie
Affiliations :
Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Publications dans "Arachidonate 12-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, CA.
Publications dans "Arachidonate 12-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, United States.
Publications dans "Arachidonate 12-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
Publications dans "Arachidonate 12-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Publications dans "Arachidonate 12-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Department of Integrative Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea.
Publications dans "Arachidonate 12-lipoxygenase" :
4 publications dans cette catégorie
Affiliations :
Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea. deokkun@konkuk.ac.kr.
Department of Integrative Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea. deokkun@konkuk.ac.kr.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Medicine and Pharmacology, New York Medical College, Valhalla, NY 10595, USA.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730 People's Republic of China.
Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, 100005 People's Republic of China.
Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730 People's Republic of China.
Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing, 100005 People's Republic of China.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology, University of Michigan, Ann Arbor, MI.
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Hacettepe University, Institute of Neurological Sciences and Psychiatry, Ankara, Turkey.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Herman B. Wells Center for Pediatric Research, and.
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana 46202.
Pediatrics.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Cellular and Integrative Physiology, and.
Herman B. Wells Center for Pediatric Research, and.
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana 46202.
Pediatrics.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Herman B. Wells Center for Pediatric Research, and stersey@iu.edu.
Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana 46202.
Pediatrics.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate 12-lipoxygenase" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan. Electronic address: toshiko@fhw.oka-pu.ac.jp.
Publications dans "Arachidonate 12-lipoxygenase" :
The prevalence of metabolic syndrome is increasing worldwide. Clinical guidelines consider metabolic syndrome as an all or none medical condition. One proposed method for classifying metabolic syndrom...
In this study, we used data from the Tehran Lipid and Glucose Cohort Study (TLGS). 4857 participants aged over 20 years with complete information on exposure (smoking) and confounders in the third pha...
Based on the results of IPTW which compared the low, medium and high risk classes of metabolic syndrome (compared to a class without metabolic syndrome), no association was found between smoking and t...
Based on the results, the causal effect of smoking on latent hazard classes of metabolic syndrome can be different based on the type of PS method. In adjusted analysis, no relationship was observed be...
Latent class analysis (LCA) offers a powerful analytical approach for categorizing groups (or "classes") within a heterogenous population. LCA identifies these hidden classes by a set of predefined fe...
Borderline personality disorder (BPD) is characterized by instability in interpersonal, affective, cognitive, self-identity, and behavioral domains. For a BPD diagnosis, individuals must present at le...
South Africa has the largest burden of HIV worldwide and has a growing burden of non-communicable diseases; the combination of which may lead to diseases clustering in ways that are not seen in other ...
Data were analyzed from the South African Demographic and Health Survey 2016. A latent class analysis (LCA) was conducted using nine disease conditions. Sociodemographic and behavioral factors associa...
Multimorbid participants were included (...
This study affirmed that integrated care is urgently needed, evidenced by the largest disease class being an overlap of chronic infectious diseases and non-communicable diseases. This study also highl...
We propose a two-step estimator for multilevel latent class analysis (LCA) with covariates. The measurement model for observed items is estimated in its first step, and in the second step covariates a...
Neonatal risk factors, such as preterm birth and low birth weight, have been robustly linked to neurodevelopmental deficits, yet it is still unclear why some infants born preterm and/or low birth weig...
Neonates who received neonatal care at an academic public hospital during an almost 10-year period (n = 19,951) were included in the latent class analysis, and 21 neonatal indicators of health were us...
The best fitting model included five infant classes: healthy, hypoxic, critically ill, minorly ill, and complicated delivery. Scores on the parent-rated neurodevelopmental measure differed by class su...
The current study extends the understanding of risk factors in neurodevelopment by including several neonatal medical conditions that are often overlooked and by using a person-centered, as opposed to...
An intersectionality framework recognizes individuals as simultaneously inhabiting multiple intersecting social identities embedded within systems of disadvantage and privilege. Previous research link...
We analyzed data from a cohort of 2,286 pregnant participants (Black, n = 933; Hispanic, n = 471; White, n = 853; and Other, n = 29) from the Centering and Racial Disparities trial. Perceived discrimi...
Four discrimination subgroups were identified: no discrimination, general discrimination, discrimination attributed to one or several social identities, and discrimination attributed to most or all so...
Perceived discrimination may play an influential role in shaping perinatal health. More research applying an intersectional lens to the study of discrimination and perinatal health outcomes is needed....
Recent studies have shown that anticoagulant therapy has heterogeneous treatment effects on patients with sepsis-induced coagulopathy (SIC)....
To identify the latent phenotypes of patients with SIC....
Retrospective cohort study....
We obtained data of patients with SIC from the Medical Information Mart for Intensive Care IV database. SIC subphenotypes were identified by latent class analysis (LCA) and K-means clustering. Clinica...
We identified 4,993 patients with SIC. The LCA and K-means clustering analysis robustly identified three subphenotypes of SIC. Class 1 patients (n = 1,808) had the lowest blood cell counts (leukocytes...
Three SIC subphenotypes were defined using clinical findings and laboratory variables. The effects of heparin treatment differ between the subphenotypes. This finding will facilitate the identificatio...
Despite evidence demonstrating the effectiveness of the COVID-19 vaccine, vaccine hesitancy has emerged as a major challenge for vaccine uptake. The objective of this study was to classify latent typo...
We employed a cross-sectional household survey among 1,112 individuals aged 18 and above who were partially vaccinated (one dose) or not vaccinated at the time of the survey. Data was collected in Aug...
Using latent class analysis we found a four-class solution for vaccine hesitancy typologies. The identified classes were strong vaccine acceptors (30%); vaccine acceptors with some concerns (7%); vacc...
Half of the study participants were in the vaccine rejectors class. Individuals in the vaccine sceptics and rejector classes evidenced lower vaccine knowledge and worse COVD-19 prevention practices an...
General practitioners (GPs) were on the front line of the COVID-19 outbreak. Identifying clinical profiles in COVID-19 might improve patient care and enable closer monitoring of at-risk profiles....
To identify COVID-19 profiles in a population of adult primary care patients, and to determine whether the profiles were associated with negative outcomes and persistent symptoms....
In a prospective multicentre study, 44 GPs from multiprofessional primary care practices in the Paris area of France recruited 340 consecutive adult patients (median age: 47 years) with a confirmed di...
A latent class (LC) analysis with 11 indicators (clinical signs and symptoms) was performed. The resulting profiles were characterised by a 3-month composite outcome (COVID-19-related hospital admissi...
We identified six profiles: 'paucisymptomatic' (LC1, 9%), 'anosmia and/or ageusia' (LC2, 12.9%), 'influenza-like syndrome with anosmia and ageusia' (LC3, 15.5%), 'influenza-like syndrome without anosm...
Our findings might help GPs to identify patients at risk of persistent COVID-19 symptoms and hospital admission and then set up procedures for closer monitoring....